Funding will support improved detection, diagnosis, prevention, and treatment of infections related to cystic fibrosis.
Site Search
Program Aimed at Advancing Search for Therapies Targeting Most Common Mutation of CF
Revised Law Includes Designated Funding for Rare Diseases
The Cystic Fibrosis Foundation announced a new set of research agreements to drive progress on its Path to a Cure. The nine awards will advance a variety of tools and strategies to accelerate treatments for the underlying cause of cystic fibrosis for all people with CF, regardless of their mutations.
Cystic Fibrosis Foundation Drug Development Model Spawns More Than 30 Promising Therapies
New funding will support clinical development of two novel therapies to address complications of cystic fibrosis
Potential treatment from Calithera Biosciences minimizes growth of germs in the lungs
New Agreement Increases Potential Payments to EPIX by up to $37.7 Million